Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
April 25, 2011 1
Glycoproteomic analysis of formalin-fixed and paraffin-embedded tissues and OCT-
embedded frozen tissues
Yuan Tian, Kay Gurley, Steve G. Bova, Christopher J. Kemp, and Hui Zhang
Introduction
April 25, 2011 2
FFPE tissues and OCT-embedded tissues are commonly used and archived with pathological and clinical information;
Applications: Histology Immunohistochemistry for molecular marker In situ hybridization Proteomics
FFPE: Formalin- Fixed Paraffin-EmbeddedOCT: Optimal Cutting Temperature compound
April 25, 2011 3
Glycoproteins as Serum Tumor Markers
• Prevalent in extracellular proteins• Most likely detected as surrogate markers• Altered glycosylation associated with cancer • All FDA approved protein serum markers are
glycoproteins
Introduction
Introduction
April 25, 2011 4
Can these processed tissues be used for proteomics analysis by mass spectrometer?
OCT compound consists of a resin-polyvinyl alcohol, benzalonium chloride, an antifungal agent, and polyethylene glycol to lower the freezing temperature
Glycosylation is preserved in the embedded tissues?
Aim
April 25, 2011 5
To investigate the feasibility of glycoproteomic analysis using FFPE tissue and OCT-embedded frozen tissue
April 25, 2011 6
Solid phase extraction of glycopeptides (SPEG) and quantitative glycoproteomics
Zhang, H. Li, X-J, Martin, D. M., and Aebersold, R. Nature Biotechnology (2003).
Tian, Y., Zhou, Y., Elliott, S., Aebersold, R., and Zhang. H. Nature Protocols (2007).
Zhou, Y. et al. Isolation of N-linked glycopeptides from plasma. Analytical Chemistry (2007).
Zou, Z., Ibisate, M., Zhou, Y., Aebersold, R. Xia, Y., and Zhang, H. Synthesis and Evaluation of Superparamagnetic Nanoparticles for Extraction of Glycopeptides in the Microtiter Plate Format Analytical Chemistry (2008).
Hydrazide beadsGlycansOxidized glycans
Proteolysis
Oxidation
Coupling
Wash
Release
Method
April 25, 20117
Plasma1606 glycosites
Prostate cancer tissues/cells517 glycosites
Liver metastasis
262 glycosites
Bladder cancer tissues202 glycosites
Breast cancer tissues/cells1208 glycosites
B and T lymphocytes407 glycosites
489 103
149
131239
Zhang, H. et al. UniPep,a database for human N-linked glycosites: AResource for BiomarkerDiscovery. GenomeBiology (2006).
Zhang, H. et al. Mass spectrometric detection of tissue-derived proteins in blood.Molecular & Cellular Proteomics (2007)
Ovarian cancer tissues/cells1022 glycosites
455
Studies
April 25, 2011 8
I. Glycoprotein analysis of FFPE tissue vs. frozen tissue
De-paraffinization & rehydration
Frozen lung
Peptide solublization
Glycopeptide isolation
LC-MS/MS analysis
SpecArray analysis IdentificationIdentification
FFPE lung
Peptide solublization
Glycopeptide isolation
LC-MS/MS analysis
Studies
April 25, 2011 9
1. Unique glycosylation sites
I. Glycoprotein analysis of FFPE tissue vs. frozen tissue
Tian Y. et al J Proteome Res 2009, 8 (4), 1657-1662
252Frozen Lung
168FFPE Lung
135117 33
Studies
April 25, 2011 10
I. Glycoprotein analysis of FFPE tissue vs. frozen tissue
2. Tryptic ends & missed cleavage sites
Tian Y. et al J Proteome Res 2009, 8 (4), 1657-1662
% of 1 tryptic end
% of 2 tryptic end % of -R % of -K missed cleavage
site %
FFPE lung 63.10 36.9 51.63 48.37 16.07
Frozen lung 64.68 35.32 50.43 49.57 17.06
Studies
April 25, 2011 11Tian Y. et al J Proteome Res 2009, 8 (4), 1657-1662
I. Glycoprotein analysis of FFPE tissue vs. frozen tissue
3. Cellular location of identified glycoproteins
April 25, 2011 12
Studies
II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
Prostate cancer is the most common malignancy in men in the United States;
No good method to reliably distinguish aggressive from non-aggressive prostate cancer
April 25, 2011 13
AG-Tumor NAG-Tumor
Glycopeptides Glycopeptides
Isotope labeling
Mass spectrometry
Validation
SPEG method
iTRAQ-8plex
Antibody Based Assay
Identification & Quantitation
AG1 AG2 AG3 AG4 NAG1 NAG2 NAG3 NAG4
AG1 AG2 AG3 AG4 NAG1 NAG2 NAG3 NAG4118 119113 114 115 121 116 117
April 25, 2011 14
A B
Studies II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
microfibrillar-associated protein 4_pep1
AG-tumor
NAG-tumor
0
5000
10000
15000
inte
nsity
P value: 0.001
periostin
AG-tumor
NAG-tumor
0
20000
40000
60000
80000
inte
nsity
P value: 0.031
April 25, 2011 15
C D
Studies II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
cathepsin L
AG-tumor
NAG-tumor
0
5000
10000
15000
20000
inte
nsity
P value: 0.016
collagen XII
Ag-tumor
NAG-tumor
0
20000
40000
60000
80000
100000
inte
nsity
P value: 0.080
April 25, 2011 16
NAT1 NAT2 NAT3 NAT4 AT1 AT2 AT3 AT4 PeriostinCathepsin LControl
Verification using Western blot
Studies II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
April 25, 2011 17
Verification using immunohistochemistryCathepsin L H&E staining 600X100X
Primary prostate cancer
Normal
II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
Studies
April 25, 2011 18
Verification using immunohistochemistryCathepsin L
Normal Prostate
LN Met
Spleen Met
Liver Met
Posterior SubduraMet
Pericardial Bulk Met
Studies II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
April 25, 2011 19
Verification using immunohistochemistry
Studies
Periostin
II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
H&E staining
600X100X
Normal
Primary prostate cancer
April 25, 2011 20
Verification using immunohistochemistry
Studies
Periostin
Normal Prostate
LN Met
Prostate cancer
Liver Met
II. Identification of glycoproteins associated with aggressive prostate cancer using OCT-embedded tissues
Conclusion
April 25, 2011 21
FFPE tissues and OCT-embedded frozen tissues are feasible to be used in glycoproteomics analysis
Glycans can be used as tags to isolate glycoproteins from FFPE and OCT-embedded biospecimens
Acknowledgements
April 25, 2011 22
Hui Zhang Daniel ChanXiaer SunG. Steve BovaDylan BachRobert N. ColeRobert O’Meally
Johns Hopkins University
NIH/NCIEarly Detection Research Network (EDRN)Patrick C. Walsh Prostate Cancer Research Fund
Grant support
Christopher J. KempKay Gurley
Fred Hutchinson Cancer Research Center